Home \ Neurology
Library

Neurology

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

What you need to know about cognitive impairment

S.R. Shakirzyanova

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE" SEPTEMBER 2025

Read more

The main mechanisms of development of cognitive impairment

A.N. BOGOLEPOVA

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Read more

Oxidate Stress in the Pathogenesis of Chronic Headache

Fedin A.I.

Read more

Possibilities of neurocytoprotheiation during reperfusion therapy

Authors:
SHCHUKIN I.A. 1*, 2*, KOLTSOV I.A. 1*, 2*, FIDLER M.S. 1*, GLUKHAREVA A.P. 1*

1* Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
2* Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Read more

The dynamics of domains of emotional-cognitive and motor disorders in the structure of the PIT syndrome in patients who have undergone acute cerebral failure

Authors:
BELKIN V.A., VASILCHENKO I.E., BELKIN A.A.

Read more

Modern approaches to the diagnosis and treatment of autonomic dysfunction syndrome in children

Author:
NEMKOVA S.A.

FGAOU in Russian National Research Medical University named after N.I. Pirogov "of the Ministry of Health of Russia (Pirogov University), Moscow, Russia

Read more

Vegetative dysfunction in patients with cerebrovascular diseases and metabolic syndrome

Author:
V.N. SHISHKOVA
, Federal State Budgetary Institution National Medical Research Center for Therapeutic and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia

Read more

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

Registered on ClinicalTrials 

A.A. BELKIN, V.A. BELKIN, I.E. VASILCENKO, E.A. PINCHUK
ANO "Clinical Institute of the Brain", Sverdlovsk region, Berezovsky, Russia

Link to the study here

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2024, Vol. 124, No. 4

Read more

The effectiveness of the use of Mexidol in combination with revascularization of the brain in the treatment of ischemic stroke

Authors:
A.M. ALASHEEV1, E.V. LANTSOVA2
1State Healthcare Institution of the Sverdlovsk Region “Sverdlovsk Regional Clinical Hospital No. 1”, Yekaterinburg, Russia;
2OOO “Sciencefiles”, Yekaterinburg, Russia

Read more

Cognitive disorders in patients with arterial hypertension

Authors:
V.V. ZAKHAROV,P.A. CHERNOUSOV,, K.A. VEKHOVA1A.N. BOGOLEPOVA3
1I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia;
2N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia;
3Federal Center for Brain and Neurotechnology, Federal Medical and Biological Agency of Russia, Moscow, Russia

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2024, Vol. 124, No. 4, Issue 2

Read more

Neurometabolic therapy of moderate cognitive disorders in patients with chronic brain ischemia

Authors:
E.A. ANTIPENKO1, A.V. SHULYNDIN2, K.M. BELYAKOV3

1Federal State Budgetary Educational Institution of Higher Education, Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia;
2Vectorpharm LLC, Moscow, Russia;
3Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko, Nizhny Novgorod, Russia

Read more

Treatment of patients with ischemic stroke in the vertebral-baslar system in the acute period: Experience in the use of the neuroprotective drug Mexidol

Authors:
Z. A. GONCHAROVA, I. V. CHERNIKOVA, V. A. NAZAROVA, V. V. TOLMACHEVA, K. G. OVSEPYAN
Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia

Read more

The use of Mexidol in patients with mild (moderate) cognitive disorders: the results of meta -analysis

Author:
V.V. ZAKHAROV, N.V. VAKHNINA
Federal State Autonomous Educational Institution of Higher Education “First Moscow State Medical University named after I.M. Sechenov” of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia

Read more

The effect of therapy with the drug Mexol on the regression of neurological deficiency and a functional outcome in patients with ischemic stroke: a systematic review and meta analysis

Authors:
I.A. VOZNYUK1,2, S.V. KOLOMETSEV2,3, E.M. MOROZOVA1

Read more

Arterial hypertension and cognitive disorders. The gaze of a neurologist

Author:
A.I. FEDIN

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Read more

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. ZAKHAROV1, A.I. FEDIN2, E.A. MKHITARYAN2,3

Read more
1 2 3 … 6

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com